Management of Elevated Blood Pressure at 38 Weeks Gestation

Immediate Assessment and Classification

The American College of Cardiology recommends confirming hypertension with repeat measurements, with BP ≥140/90 mmHg defining hypertension in pregnancy, in patients at 38 weeks gestation 1, 2
For severe hypertension (≥160/110 mmHg), the European Society of Cardiology recommends confirmation within 15 minutes and initiation of urgent treatment, to prevent maternal stroke and other complications 1, 2, 3
The American Heart Association suggests that gestational hypertension is characterized by new-onset hypertension after 20 weeks without proteinuria or end-organ dysfunction, and preeclampsia is characterized by hypertension plus proteinuria or evidence of maternal organ dysfunction 1, 2, 3

The American College of Obstetricians and Gynecologists recommends urgent treatment for severe hypertension (≥160/110 mmHg) in a monitored setting, with first-line medications including oral nifedipine, intravenous labetalol, and intravenous hydralazine 1, 3
The European Society of Cardiology suggests targeting a systolic blood pressure of 110-140 mmHg and diastolic blood pressure of 85 mmHg, while avoiding excessive blood pressure reduction below diastolic 80 mmHg 1, 4

The American College of Obstetricians and Gynecologists recommends administering magnesium sulfate if the patient has preeclampsia with severe hypertension or neurological signs and symptoms, with a loading dose of 4-5g IV over 5 minutes and maintenance of 1-2g/hour continuous IV infusion 1, 4, 5

The European Society of Cardiology recommends continuous blood pressure monitoring, assessment for deep tendon reflexes and clonus, and evaluation for symptoms such as severe headache and visual disturbances, in patients with hypertensive disorders of pregnancy 1, 6, 4
The American Heart Association suggests repeating laboratory tests, including hemoglobin and platelet count, liver enzymes, creatinine, and uric acid, at least twice weekly or more frequently if clinical deterioration occurs 1, 4

The American College of Obstetricians and Gynecologists recommends electronic fetal heart rate monitoring and ultrasound for fetal biometry, amniotic fluid volume, and umbilical artery Doppler, in patients with hypertensive disorders of pregnancy 1, 6, 4
The European Society of Cardiology suggests serial fetal surveillance every 2 weeks if initial assessment is normal, and more frequent monitoring if fetal growth restriction is identified 4

The American College of Obstetricians and Gynecologists recommends delivery at 38 weeks gestation, regardless of the specific hypertensive disorder or severity, with immediate delivery after maternal stabilization with blood pressure control 1, 6, 4
The European Society of Cardiology suggests that vaginal delivery is preferred unless cesarean is indicated for standard obstetric reasons, and induction of labor is appropriate 3, 5

The ISSHP guidelines recommend delivery at 38-39 weeks gestation with any hypertensive disorder, regardless of cervical favorability or active labor status, as conservative management is only appropriate for preeclampsia at <34 weeks gestation at specialized centers 7
The American College of Obstetricians and Gynecologists (ACOG) and ISSHP guidelines suggest that gestational age ≥37 weeks with severe hypertension mandates delivery after maternal stabilization to prevent life-threatening maternal complications including stroke, eclampsia, and end-organ damage 7, 8

Blood pressure ≥160/110 mmHg represents a hypertensive emergency requiring urgent treatment and delivery planning, as it serves as a surrogate marker for stroke risk, according to the American Heart Association 7, 8
The CHIPS trial follow-up data demonstrated that severe hypertension is associated with significantly greater likelihood of adverse outcomes for both mother (thrombocytopenia, abnormal liver enzymes, longer hospital stay) and baby (low birth weight, prematurity, death, neonatal unit care) 7, 8
The International Society for the Study of Hypertension in Pregnancy (ISSHP) states that maternal deaths from hypertensive episodes, subarachnoid hemorrhage, and rupture of the uterus have been reported with oxytocic drugs used for labor induction/augmentation in hypertensive patients 7, 8

The ISSHP guidelines state that delivery is mandatory when ≥1 of the following emerges: inability to control BP despite ≥3 antihypertensive classes, maternal pulse oximetry <90%, progressive deterioration in liver function, creatinine, hemolysis, or platelet count, ongoing neurological features, placental abruption, or non-reassuring fetal status 7, 8
The ACOG recommends that blood pressure level alone does not reliably stratify risk—serious organ dysfunction can develop at relatively mild hypertension levels, and approximately 25% of gestational hypertension cases progress to preeclampsia 7, 8